4//SEC Filing
Goodrich Katherine 4
Accession 0002044770-26-000002
CIK 0001819790other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 7:32 PM ET
Size
7.0 KB
Accession
0002044770-26-000002
Insider Transaction Report
Form 4
Goodrich Katherine
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2025-12-15+2,233→ 2,233 total - Exercise/Conversion
Restricted Stock Units
[F2][F3]2025-12-15−2,233→ 4,467 total→ Common Stock (2,233 underlying)
Footnotes (3)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F2]Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F3]The RSUs will vest in three equal installments on December 15th of 2025, 2026 and 2027, subject to the Reporting Person's continuous service.
Signature
/s/ Scott Sieckert, Attorney-in-Fact|2026-01-14
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0002044770
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 7:32 PM ET
- Size
- 7.0 KB